Literature DB >> 13989434

Purification of the third factor of anthrax toxin.

H SMITH, J L STANLEY.   

Abstract

Entities:  

Keywords:  ANTHRAX; TOXINS AND ANTITOXINS

Mesh：

Substances：

Year:  1962        PMID： 13989434     DOI： 10.1099/00221287-29-3-517

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN： 0022-1287


× No keyword cloud information.
  13 in total

1.  THE CHEMICAL BASIS OF THE VIRULENCE OF BACILLUS ANTHRACIS. IX. ITS AGGRESSINS AND THEIR MODE OF ACTION.

Authors:  J KEPPIE; P W HARRIS-SMITH; H SMITH
Journal:  Br J Exp Pathol       Date:  1963-08

2.  Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein.

Authors:  T J Goletz; K R Klimpel; N Arora; S H Leppla; J M Keith; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 3.  Mechanisms of bacterial pathogenicity that involve production of calmodulin-sensitive adenylate cyclases.

Authors:  H R Masure; R L Shattuck; D R Storm
Journal:  Microbiol Rev       Date:  1987-03

Review 4.  Bacterial toxins: a table of lethal amounts.

Authors:  D M Gill
Journal:  Microbiol Rev       Date:  1982-03

5.  Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells.

Authors:  Y Singh; K R Klimpel; S Goel; P K Swain; S H Leppla
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  Bacillus anthracis has two independent bottlenecks that are dependent on the portal of entry in an intranasal model of inhalational infection.

Authors:  David E Lowe; Stephen M C Ernst; Christine Zito; Jason Ya; Ian J Glomski
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

Review 7.  Cellular and systemic effects of anthrax lethal toxin and edema toxin.

Authors:  Mahtab Moayeri; Stephen H Leppla
Journal:  Mol Aspects Med       Date:  2009-07-26

8.  Purification and properties of in vitro-produced anthrax toxin components.

Authors:  D C Fish; B G Mahlandt; J P Dobbs; R E Lincoln
Journal:  J Bacteriol       Date:  1968-03       Impact factor: 3.490

9.  Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin.

Authors:  K R Klimpel; S S Molloy; G Thomas; S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Potent antitumor activity of a urokinase-activated engineered anthrax toxin.

Authors:  Shihui Liu; Hannah Aaronson; David J Mitola; Stephen H Leppla; Thomas H Bugge
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.